Mechanisms underlying the vascular activity of β-amyloid protein fragment (βA425-35) at the level of skin microvasculature

Brain Research

Volumn 736, Issue 1-2, 1996, Pages 206-216

  Khalil, Zeinab ^a   Chen, Hai bo ^b   Helme, Robert D ^a  

^a NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^b National Center of Gerontology   (China)

Author keywords

ageing; amyloid peptide; endothelin; microvasculature; substance P

Indexed keywords

AMYLOID BETA PROTEIN; BISINDOLYLMALEIMIDE; BRADYKININ; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; N(G) NITROARGININE; NITRIC OXIDE; PROTEIN KINASE C; SEROTONIN;

ADOLESCENT; AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BLISTER; CONTROLLED STUDY; DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN;

EID: 0030583638     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00685-3     Document Type: Article

References (62)

1. [1] Andrews, P.V., Thomas, K. and Helme, R.D., NK-1 receptor mediation of plasma extravasation in rat skin. Br. J. Pharmacol., 97 (1989) 1232-1238.
2. [2] Behl, C., Davis, J.B., Lesley, R. and Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity, Cell, 77 (1994) 817-827.
3. [3] Boland, K., Manias, K. and Perlmutter, D.H., Specificity in recognition of amyloid-β peptide by Serpin-enzyme complex receptor in hepatoma cells and neuronal cells. J. Biol. Chem., 270 (1995) 28022-28028.
4. [4] Brain, S.D. et al., Calcitonin gene-related peptide is a potent vasodilator, Nature, 13 (1985) 54-56.
5. [5] Brain, S.D., Tippins, J.R. and Williams, T.J., Endothelin induces potent microvascular constriction, Br. J. Pharmacol., 95 (1988) 1005-1007.
6. [6] Brain, S.D., Crossman, D.C., Buckley, T.L. and Williams, T.J., Endothelin-1: demonstration of potent effects on the microcirculation of humans and other species, J. Cardiovasc. Pharmacol., 13 (suppl. 5)(1989)S147-S149.
7. [7] Chahl, L.A., Interactions of substance P with putative mediators of inflammation and ATP, Eur. J. Pharmacol., 44 (1977) 45-49.
8. [8] Chander, C.L., Moor, A.R., Desa, F.M., Howat, D. and Willoughby, D.A., The local modulation of vascular permeability by endothelial cell derived products, J. Pharm. Pharmacol., 40 (1988) 745-746.
9. 125I] endothelin in humans, pigs, and rats: functional relevance in humans, J. Cardiovasc. Pharmacol., 13 (suppl. 5) (1989) S166-S170.
10. 125I] ET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in adult rat brain and neurone-enriched primary cultures of embryonic brain cells, Brain Res., 554 (1991) 278-285.
11. [11] De Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T.D. and Vane. J.R., Pressor effects of circulationg endothelin are limited by its removal in the pulmonary circulation and by release of prostacyclin and endothelium-derived relaxing factor, Proc. Natl. Acad. Sci. USA, 85 (1988) 9797-9800.
12. [12] Dohi, Y. and Luscher, T.F., Ageing differentially affects direct and indirect actions of endothelin-1 in perfused mesenteric arteries of the rat, Br. J. Pharmacol., 100 (1990) 889-893.
13. [13] D'Orleans-Juste, P., Finet, M., De Nucci, G. and Vane, J.R., Pharmacology of endothelin-1 in isolated vessels, effect of nicardipine, methylene blue, hemoglobin and gossypol, J. Cardiovasc. Pharmacol., 13 (Suppl. 5) (1989) 19-22.
14. [14] Fiacco, M.D., Levanti, M.C., Dessi, M.L. and Zucca, G., The human hippocampal formation and parahippocampal gyrus: localisation of substance P-like immunoreactivity in newborn and adult post-mortem tissue, Neuroscience, 21 (1987) 141-150.
15. [15] Forloni, G., Chiesa, R., Smiroldo, S., Verga, L., Salmona, M., Tagliavini, F. and Angertti, N., Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35, Neuroreport, 4 (1993) 523-526.
16. [16] Fortez, Z.B., De Nucci, G. and Garcia-Leme, J., Effect of endothelin-1 on arterioles and venules in vivo, J. Cardiovasc. Pharmacol., 13 (suppl. 5) (1989) S200-S201.
17. [17] Fortez, Z.B., Scivoleto, R. and Garcia-Leme, J., Endothelin-1 induces potent constriction of lymphatic vessels in situ, Eur. J. Pharmacol., 170 (1989) 69-73.
18. [18] Furchggot, R.F. and Zawadski, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288 (1980) 373-376.
19. [19] Golden, C.L., Kohler, J.P., Nick, H.S. and Visner, G.A., Effects of vasoactive and inflammatory mediators on endothelin-1 expression in pulmonary endothelial cells, Am. J. Resp. Cell. Mol. Biol., 12 (1995) 503-512.
20. [20] Grammas, P., Botchlet, T., Fugate, R., Ball, M.J. and Roher, E.A., Alzheimer disease amyloid proteins inhibit brain endothelial cell proliferation in vitro, Dementia, 6 (1995) 126-130.
21. [21] Gu, X.H., Liu, J.J., Dilon, J.J. and Nayler. W.G., The failure of endothelin to displace bound, radioactively-labelled calcium antagonists (PN 200/110, D888 and diltiazem), Br. J. Pharmacol., 96 (1989) 262-264.
22. [22] Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauichi, T., Goto, K. and Masaki, T., The human endothelin family: three seperate genes, Proc. Natl. Acad. Sci. USA, 86 (1989) 2863-2867.
23. [23] Itagaki. S., McGeer, P.L., Akiyama, H., Zhu, S. and Selkoe, D., Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease, J. Neuroimmunol., 24 (1989) 173-182.
24. 125I] endothelin in rat and human brain, Neurosci. Lett., 97 (1989) 276-279.
25. 1rantitrypsin-elastase complex, J. Biol. Chem., 266 (1991) 11282-11289.
26. [26] Joslin, G., Krause, J.E., Hershey, A.D., Adams. S.P., Fallon, R.J. and Perlmutter, D.H., β-Amyloid peptide, substance P, and bombesin to the serpin-enzyme complex receptor, J. Biol. Chem., 266 (1991) 21897-21902.
27. 1-antitrypsin-elastase complexes and amyloid-peptide, Am. Soc. Clin. Invest., 90 (1992) 1150-1154.
28. [28] Kalaria, R.N. and Hedera, P., Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport, 6 (1995) 477-480.
29. [29] Khalil, Z. and Helme, R.D., The quantitative contribution of nitric oxide and sensory nerves to bradykinin-induced inflammation in rat skin microvasculature. Brain Res., 589 (1992) 102-108.
30. [30] Khalil, Z., Ralevic, V., Bassirat, M., Dusting, G.J. and Helme, R.D., Effects of ageing on sensory nerve function in rat skin, Brain Res., 641 (1994) 265-272.
31. 425-35 modulates substance P effect on rat skin microvasculature in aged rats: pharmacological manipulation using SEC receptor ligands, Brain Res., 651 (1994) 227-235.
32. [32] Klemm, P., Warner, T.D., Hohlfeld, T., Corder, R. and Vane, J.R., Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines, Proc. Natl. Acad. Sci. USA, 92 (1995) 2691-2695.
33. [33] Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. and Yankner, B.A., An in vivo model for the neurodegenerative effects of β-amyloid and protection of substance P, Proc. Natl. Acad. Sci. USA, 88 (1991) 7247-7251.
34. [34] Krsmanovic, L.Z., Stojilkovic, S.S., Balla, T., Al-Damluji, S., Weiner, R.L. and Catt, K.J., Receptors and neurosecretory actions of endothelin in hypothalamic neurones, Proc. Natl. Acad. Sci. USA, 88 (1991) 11124-11128.
35. [35] Lee. M.E., de la Monte, S.M., Ng, S.C., Bloch, K.D. and Quertermous, T., Expression of the potent vasoconstrictor endothelin in the human central nervous system, J. Clin. Invest., 86 (1990) 141-147.
36. 6-glioma and celebellar granule cells, Biochem. Biophys. Res. Commun., 168 (1990) 512-519.
37. [37] Luscher, T.F., Yang, Z., Tschudi, M., Von Segresser, L., Stulz, P., Boulanger, C., Siebenmann, R., Turina, M. and Buhler, F.R., Interaction between endothelin-1 and endothelium derived relaxing factor in human arteries and veins, Circ. Res., 66 (1990) 1088-1094.
38. [38] Masters, C.L., Simms, G., Weinmann, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K., Amyloid plaque core protein in Alzheimer's disease and Downs syndrome, Proc. Natl. Acad. Sci. USA, 82 (1985) 4245-4249.
39. [39] Mattson, M.P., Tomaselli, K.J. and Rydel, R.E., Calcium destabilizing and neurodegenerative effects od aggregated beta-amyloid peptide are attenuated by basic FGF, Brain Res., 621 (1993) 35-49.
40. [40] Matsumoto, H., Suzuki, N., Onda, H. and Fujino, M., Abundance of endothelin-3 in rat intestine, pitutary gland and brain, Biochem. Biophys. Res. Commun., 164 (1989) 74-80.
41. [41] Minami, M., Kimura, M., Iwamoto, N. and Arai, H. Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 19 (1995) 509-513.
42. [42] Mitsuhashi, M., Akitaya, T., Turk, C.W. and Payan, D.G., Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cell, Mol. Brain Res., 11 (1991) 177-180.
43. [43] Miyauchi, T., Yanagisawa, M., Suzuki, N., Ilda, K., Sugishita, Y., Fujino, M., Saito, T., Goto, K. and Masaka, T., Venous plasma concentrations of endothelin-1 in normal and hypertensive subjects, Circulation, 80 (Suppl. II) (1989) 573.
44. 2 and prostacyclin, Pharmacol. Rev., 30 (1979) 293-331.
45. G-nitro arginine (L-NOARG), a novel L-arginine-reversible inhibitor of endothelium-dependent vasodiatation in vitro, Br. J. Pharmacol., 99 (1990) 408-412.
46. [46] Ohlen, A., Raud, J., Hedqvist, P. and Wiklund, N.P., Microvascular effects of endothelin in the rabbit tenuissimus muscle and hamster cheek pouch, Microvasc. Res., 37 (1989) 115-118.
47. [47] Palmer, R.M.J., Ferrige, A.G. and Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 333 (1987) 524-526.
48. [48] Perlmutter, D.H., Glover, G.I., Givetna, M., Schasteen, C.S. and Fallon, R.J., Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes, Proc. Natl. Acad. Sci. USA, 87 (1990) 3753-3757.
49. [49] Perlmutter, L.S., Microvascular pathology and vascular basement membrane components in Alzheimer's disease, Mol. Neurobiol., 9 (1994) 33-40.
50. [50] Quigley Jr., B.J. and Kowall, N.W., Substance P-like immunoreactive neurones are depleted in Alzheimer's disease cerebral cortex, Neuroscience, 41 (1991) 41-60.
51. [51] Ralevic, V., Dusting, G.J., Khalil, Z. and Helme, R.D., Nitric oxide contributes to SP-induced inflammation in rat skin microvasculature. In S. Moncada, M.A. Marletta, J.B. Higgs Jr. and E.A. Higgs (Eds.), Biology of Nitric Oxide, Portland Press, Colchester, 1992, pp. 206-208.
52. [52] Rovero, P., Patacchini, R., Renzetti, A.R., Brown, M., Mizrahi, J., Maggi, C.A. and Giachetti, A., Interaction of β-amyloid protein (25-35) with tachykinin receptors, Neuropeptides, 22 (1992) 99-101.
53. [53] Rubanyi, G.M., Endothelium-derived vasoconstrictor factors. In U.S. Ryan (Ed.), Endothelial Cells, Vol. 3, CRC Press, Boca Raton, pp. 61-74.
54. [54] Shimohigashi, Y., Matsumoto, H., Takano. Y., Saito, R., Iwata, T., Kamiya, H.O. and Ohno, M., Receptor mediated specific biological activity of a β-amyloid protein fragment for NK-1 substance P receptors, Biomed. Biophys. Res. Commun., 193 (1993) 624-630.
55. [55] Suzuki. N., Matsumoto, H., Kitada, C., Yanagisawa, M., Miyauchi, T., Masaka, T. and Fugino, M., Immunoreactive endothelin-1 in plasma detected by a sandwich-type enzyme immunoassay, J. Cardiovasc. Pharmacol., 13 (Suppl. 5) (1989) 151-152.
56. [56] Tabuchi, Y., Nakamaru, M., Rakugi, H., Nagano, M. and Ogihara, T., Endothelin-1 enhances adrenergic vasoconstriction in perfused rat mesenteric arteries, Biochem. Biophys. Res. Commun., 159 (1989) 1304-1308.
57. [57] Thomas, K.L., Andrews, P.V., Khalil, Z. and Helme, R.D., Substance P induced hydrolysis of inositol phospholipids in rat skin in an in vivo model of inflammation, Neuropeptides, 13 (1989) 191-196.
58. [58] Urakami, K., Okada, A., Ohno, K., Kitaguchi, N., Tanaka, S., Nakamura, S. and Takahashi, K., Amyloid beta protein precursor with Kunitz-type protease inhibitor domains (APPI) in cerebrospinal fluid and APPmRNAs in cultured skin fibroblasts of patients with Alzheimer's disease, Tohoku. J. Exp. Med., 174 (1994) 199-207.
59. [59] Warner, T.D., Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds - comparison of their vasoconstrictor and vasodilator responses to agonists, Br. J. Pharmacol., 99 (1990) 427-436.
60. [60] Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yasaki, Y., Goto, K. and Masaki, T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332 (1988) 411-415.
61. [61] Yankner, B.A., Lawrence, K.D. and Kirschner, D.A., Neurotrophic and neurotoxic effects of β-amyloid protein: reversal by tachykinin neuropeptide, Science, 250 (1990) 279-282.
62. [62] Yue, T.L., Nambi, P., Wu, H.L. and Feuerstein, G., Endothelin receptor binding and cellular signal transduction in neurohybrid NG108-15 cells, Neuroscience, 44 (1991) 215-222.